COMMUNIQUÉ DE PRESSE publié le 11/09/2023 à 14:30, il y a 3 années Jaguar Health Shares Replay Link for September 7, 2023 Presentation at Emerging Growth Conference
COMMUNIQUÉ DE PRESSE publié le 07/09/2023 à 14:30, il y a 3 années Jaguar Health's Executive VP Dr. Karen Brunke Joins BIO's Rare Disease and Orphan Drugs Committee
COMMUNIQUÉ DE PRESSE publié le 30/08/2023 à 14:30, il y a 3 années The Science Times Publishes Article About Jaguar Health's Focus on Developing Crofelemer for Two Rare Disease Indications
COMMUNIQUÉ DE PRESSE publié le 28/08/2023 à 14:30, il y a 3 années Jaguar Health to Present September 7 at Emerging Growth Conference and at the September 11-13 H.C. Wainwright Annual Global Investment Conference
COMMUNIQUÉ DE PRESSE publié le 24/08/2023 à 13:00, il y a 3 années 1 mois Jaguar Health Engages B2i Digital to Deploy Cutting-Edge Investor Engagement Campaign
COMMUNIQUÉ DE PRESSE publié le 17/08/2023 à 14:30, il y a 3 années 1 mois Napo Pharmaceuticals, a Jaguar Health Family Company, Reports Completion of Last Patient Last Visit for its Pivotal Phase 3 OnTarget Trial of Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea
COMMUNIQUÉ DE PRESSE publié le 16/08/2023 à 14:30, il y a 3 années 1 mois Napo Pharmaceuticals Surveys of Neurologists, Patients, and Caregivers Regarding Amyotrophic Lateral Sclerosis (ALS) Treatment Indicate Real World Burden of Diarrhea and Potential Treatment Interruption
COMMUNIQUÉ DE PRESSE publié le 14/08/2023 à 14:00, il y a 3 années 1 mois Jaguar Health Reports Second Quarter 2023 Financial Results
COMMUNIQUÉ DE PRESSE publié le 10/08/2023 à 14:30, il y a 3 années 1 mois Jaguar Health to Hold Investor Webcast Monday, August 14th at 8:30 AM EDT Regarding Q2 2023 Financials & Corporate Updates
COMMUNIQUÉ DE PRESSE publié le 09/08/2023 à 14:30, il y a 3 années 1 mois Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to BARDA for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea
Publié le 24/09/2026 à 18:31, il y a 3 heures 21 minutes LNA SANTE : Mise à disposition du rapport financier semestriel 2026
Publié le 24/09/2026 à 18:00, il y a 3 heures 53 minutes GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Publié le 24/09/2026 à 18:00, il y a 3 heures 53 minutes GUILLEMOT CORPORATION : Mise à disposition du rapport financier semestriel au 30 juin 2026
Publié le 24/09/2026 à 14:55, il y a 6 heures 58 minutes Nextech3D.ai Surpasses $1 Million in New Customer Contract Value, Expands AI Software Portfolio with KATE and Grows Multi-Year Enterprise Agreements
Publié le 24/09/2026 à 14:30, il y a 7 heures 23 minutes Solitario Resources CEO to Present at the 38th Annual Mining Forum Americas 2026 Conference
Publié le 24/09/2026 à 14:00, il y a 7 heures 53 minutes Horizon Aircraft to Report First Quarter 2027 Results and Provide a Business Update on October 9, 2026
Publié le 24/09/2026 à 14:00, il y a 7 heures 53 minutes Reeflex Completes $1.23 Million Goes Order on Schedule Ahead of Vancouver Investor Conference
Publié le 24/09/2026 à 20:29, il y a 1 heure 24 minutes EQS-Adhoc: HelloFresh SE expects revenue for Q3 2026 below market expectations and adjusts outlook for the financial year 2026
Publié le 24/09/2026 à 19:00, il y a 2 heures 53 minutes HIAG provides a first-hand insight into its strategy and the added value it generates at its Capital Market Day
Publié le 24/09/2026 à 18:40, il y a 3 heures 12 minutes EQS-Adhoc: Brockhaus Technologies AG launches public share buyback offer of approx. €90 million for up to 3,592,000 shares
Publié le 24/09/2026 à 18:15, il y a 3 heures 38 minutes Epanko Value Engineering Identifies 20% Production Increase
Publié le 24/09/2026 à 18:05, il y a 3 heures 47 minutes DCK Tools Showcases Expanded Outdoor Power Equipment Lineup at Salonvert 2026
